Art Therapy in Acute Schizophrenia (KUSS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01622166|
Recruitment Status : Completed
First Posted : June 19, 2012
Last Update Posted : October 24, 2014
Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual.
*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.
*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Behavioral: psychodynamic art therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Art Therapy for Symptom Reduction in Acute Schizophrenia - a Randomised Controlled Trial (Kunsttherapie Zur Symptomreduktion Bei Akuter Schizophrenie - Eine Randomisierte Kontrollierte Pilotstudie)|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||January 2013|
Experimental: art therapy
12 sessions of art therapy / 6 weeks
Behavioral: psychodynamic art therapy
2 sessions à 1.5 hrs /week, intervention duration 6 weeks
No Intervention: TAU
treatment as usual / 6 weeks
- Change in Positive and Negative Syndrome Scale (PANSS-) scores [ Time Frame: weeks 0, 6, 12 ]assessment of change of schizophrenic positive, negative and general symptom scores
- safety measures [ Time Frame: weeks 0, 6, 12 ]number of participants with adverse events
- Change in Calgary depression Scale (CDS-) scores [ Time Frame: weeks 0, 6, 12 ]assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01622166
|Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus|
|Berlin, Germany, 10115|
|Principal Investigator:||Christiane Montag, M.D.||Charite University, Berlin, Germany|